ASXL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.88879999921221E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.604360E-04 |
Normal-vs-Stage2 |
3.984200E-04 |
Normal-vs-Stage3 |
3.13630010850829E-10 |
Normal-vs-Stage4 |
2.08889572306248E-11 |
Stage1-vs-Stage2 |
5.402200E-01 |
Stage1-vs-Stage3 |
4.979200E-04 |
Stage1-vs-Stage4 |
1.167660E-04 |
Stage2-vs-Stage3 |
6.022500E-02 |
Stage2-vs-Stage4 |
1.429820E-02 |
Stage3-vs-Stage4 |
4.418400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.73340000423295E-08 |
Normal-vs-AfricanAmerican |
2.14870000014855E-07 |
Normal-vs-Asian |
7.560000E-01 |
Caucasian-vs-AfricanAmerican |
1.850350E-01 |
Caucasian-vs-Asian |
1.110600E-01 |
AfricanAmerican-vs-Asian |
3.904000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.0104999947913E-08 |
Normal-vs-Female |
1.53645999999563E-05 |
Male-vs-Female |
1.935440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.86340000000774E-05 |
Normal-vs-Age(41-60Yrs) |
1.78988999999241E-05 |
Normal-vs-Age(61-80Yrs) |
1.20719999552321E-08 |
Normal-vs-Age(81-100Yrs) |
3.61090000000619E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.447000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.265600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.787400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.066360E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.509230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.172600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.420400E-01 |
Normal-vs-Grade 2 |
4.87130000004221E-06 |
Normal-vs-Grade 3 |
1.78590000010637E-07 |
Normal-vs-Grade 4 |
5.38800115634785E-11 |
Grade 1-vs-Grade 2 |
1.559430E-01 |
Grade 1-vs-Grade 3 |
7.295900E-02 |
Grade 1-vs-Grade 4 |
2.915700E-03 |
Grade 2-vs-Grade 3 |
1.967790E-01 |
Grade 2-vs-Grade 4 |
9.240100E-04 |
Grade 3-vs-Grade 4 |
2.458000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.317200E-03 |
Normal-vs-ccB subtype |
1.51289999972271E-07 |
ccA subtype-vs-ccB subtype |
5.179600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.59448000000006E-05 |
Normal-vs-N1 |
4.569900E-02 |
N0-vs-N1 |
6.967400E-01 |
|
|